iTRAQ-based proteomic analysis of combination therapy with taurine, epigallocatechin gallate, and genistein on carbon tetrachloride-induced liver fibrosis in rats.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Toxicology Letters

• Publication date

  2015-01-05

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.toxlet.2014.11.009PMID 25448286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.

  2014cited by this paper
• The differential diagnostic model for serous peptidomics in HBV carriers established by MALDI-TOF-MS analysis.

  2014cited by this paper
• The coagulopathy of liver disease: does vitamin K help?

  2013cited by this paper
• Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis.

  2013cited by this paper
• Combined Taurine, Epigallocatechin Gallate and Genistein Therapy Reduces HSC-T6 Cell Proliferation and Modulates the Expression of Fibrogenic Factors

  2013cited by this paper
• Advancing cancer drug discovery towards more agile development of targeted combination therapies.

  2012cited by this paper
• Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis

  2012cited by this paper
• Mechanisms of fibrosis: therapeutic translation for fibrotic disease

  2012cited by this paper
• Protective effect of Phellinus linteus polysaccharide extracts against thioacetamide-induced liver fibrosis in rats: a proteomics analysis

  2012cited by this paper
• Role of oxidative stress and molecular changes in liver fibrosis: a review.

  2012cited by this paper
• Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats.

  2012cited by this paper
• Novel Biomarker Candidates to Predict Hepatic Fibrosis in Hepatitis C Identified by Serum Proteomics

  2011cited by this paper
• Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients.

  2011cited by this paper
• Plasma membrane proteome analysis of the early effect of alcohol on liver: implications for alcoholic liver disease.

  2011cited by this paper
• Coomassie staining as loading control in Western blot analysis.

  2011cited by this paper
• Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor

  2010cited by this paper
• Dynamic expression of hepatic thioredoxin mRNA in rats with non‐alcoholic fatty liver disease

  2010cited by this paper
• Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

  2010cited by this paper
• Identification of immune responsible fibrinogen beta chain in the liver of large yellow croaker using a modified annealing control primer system.

  2009cited by this paper
• Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies

  2009cited by this paper
• Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang.

  2009cited by this paper
• iTRAQ‐coupled 2‐D LC‐MS/MS analysis of protein profile associated with HBV‐modulated DNA methylation

  2009cited by this paper
• Proteome analysis of a human liver carcinoma cell line stably expressing hepatitis delta virus ribonucleoproteins.

  2009cited by this paper
• Genistein and phycocyanobilin may prevent hepatic fibrosis by suppressing proliferation and activation of hepatic stellate cells.

  2009cited by this paper
• Cancer cell killing via ROS: To increase or decrease, that is the question

  2008cited by this paper
• Serum Hyaluronic Acid as a Noninvasive Marker of Hepatic Fibrosis in Chronic Hepatitis B

  2008cited by this paper
• Systematic review: combination therapies for treatment‐naïve chronic hepatitis B

  2008cited by this paper
• Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies

  2008cited by this paper
• Triosephosphate isomerase deficiency: Facts and doubts

  2006cited by this paper
• Comparative proteomic studies on the pathogenesis of human ulcerative colitis

  2006cited by this paper
• Expression of thioredoxin and thioredoxin-binding protein-2 in the liver of patients with chronic hepatitis C as a predictor of response to interferon therapy.

  2006cited by this paper
• Overexpression of thioredoxin prevents thioacetamide-induced hepatic fibrosis in mice.

  2005cited by this paper
• Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis.

  2005cited by this paper
• Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells.

  2005cited by this paper
• Effects of taurine on proliferation and apoptosis of hepatic stellate cells in vitro.

  2004cited by this paper
• PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation

  2004cited by this paper
• The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis.

  2004cited by this paper
• Transforming growth factor-beta-induced stimulation of formation of collagen fiber network and anti-fibrotic effect of taurine in an in vitro model of hepatic fibrosis.

  2004cited by this paper
• Oxidative Stress, Plant-Derived Antioxidants and Liver Fibrosis

  2002cited by this paper
• Is liver fibrosis reversible

  2001cited by this paper
• Is liver fibrosis reversible?

  2001cited by this paper
• Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk

  2000cited by this paper
• An algorithm for the grading of activity in chronic hepatitis C

  1996cited by this paper
• Factor VII as a marker of hepatocellular synthetic function in liver disease.

  1976cited by this paper

• Protective effects of taurine against chemical and natural compound-induced toxicity: mechanistic insights and therapeutic potential

  2025cites this paper
• The mmu_circRNA_37492/hsa_circ_0012138 function as potential ceRNA to attenuate obstructive renal fibrosis

  2022cites this paper
• Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review

  2022cites this paper
• Protective role of taurine against oxidative stress

  2021cites this paper
• Network medicine framework shows that proximity of polyphenol targets and disease proteins predicts therapeutic effects of polyphenols

  2021cites this paper
• Pomegranate peel extract ameliorates liver fibrosis induced by carbon tetrachloride in rats through suppressing p38MAPK/Nrf2 pathway

  2020cites this paper
• Chapter 10: Taurine

  2020cites this paper
• Network Medicine Framework Shows Proximity of Polyphenol Targets and Disease Proteins is Predictive of the Therapeutic Effects of Polyphenols

  2020cites this paper
• A Comprehensive Review of Natural Products against Liver Fibrosis: Flavonoids, Quinones, Lignans, Phenols, and Acids

  2020cites this paper
• Predicting the Health Impact of Dietary Polyphenols Using a Network Medicine Framework

  2020cites this paper
• Validation and functional analysis of the critical proteins in combination with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats.

  2019cites this paper
• Serum Proteomic Changes as Candidate Biomarkers of Intermediate Liver Fibrosis in Chronic Hepatitis B Infection

  2019cites this paper
• Taurine is Involved in Energy Metabolism in Muscles, Adipose Tissue, and the Liver

  2018cites this paper
• Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.

  2018cites this paper
• Immune regulation effect of lienal polypeptides extract in Lewis lung carcinoma-bearing mice treated with cyclophosphamide

  2018cites this paper
• iTRAQ-based quantitative proteomic analysis reveals important metabolic pathways for arsenic-induced liver fibrosis in rats

  2018cites this paper
• Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells

  2018cites this paper
• Identification of Tengfu Jiangya Tablet Target Biomarkers with Quantitative Proteomic Technique

  2017cites this paper
• Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data

  2017cites this paper
• Comparative Analysis of Serum Proteins from Patients with Severe and Mild EV‐A71‐induced HFMD using iTRAQ‐Coupled LC‐MS/MS Screening

  2017cites this paper
• Txn1, Ctsd and Cdk4 are key proteins of combination therapy with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats.

  2017cites this paper
• Differential Proteomic Analysis of Dimethylnitrosamine (DMN)‐Induced Liver Fibrosis

  2017cites this paper
• Maternal nutrition modulates fetal development by inducing placental efficiency changes in gilts

  2017cites this paper
• iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine

  2016cites this paper
• Investigation of the roles of trace elements during hepatitis C virus infection using protein-protein interactions and a shortest path algorithm.

  2016cites this paper
• iTRAQ-Based Proteomic Analysis of Ginsenoside F2 on Human Gastric Carcinoma Cells SGC7901

  2016cites this paper
• Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome

  2016cites this paper
• Maternal N-Carbamylglutamate Supplementation during Early Pregnancy Enhances Embryonic Survival and Development through Modulation of the Endometrial Proteome in Gilts.

  2015cites this paper
• Liver Biomarkers and Their Applications to Nutritional Interventions in Animal Studies

  2015cites this paper
• Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage

  2015cites this paper